New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
05:55 EDTDIRI, DIRI, DCO, DCO, ESIO, ESIO, PMC, PMC, ARTX, ARTX, ETAK, ETAK, FVE, FVE, SPA, SPA, SFE, SFE, LCAV, LCAVNoble Financial to host a conference
9th Annual Equity Conference is being held in Hollywood, Florida on January 22-23.
News For DIRI;SFE;SPA;FVE;ETAK;ARTX;PMC;ESIO;DCO;LCAV From The Last 14 Days
Check below for free stories on DIRI;SFE;SPA;FVE;ETAK;ARTX;PMC;ESIO;DCO;LCAV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
07:19 EDTSPASingular Research to hold a conference
Subscribe for More Information
September 17, 2014
17:27 EDTFVEFive Star Quality reports Q4 EPS (7c), consensus 5c
Reports Q4 revenue $325.2M, consensus $325.25M. Loss from continuing operations for the fourth quarter of 2013 included $1M, or 2c per basic and diluted share, of general and administrative expenses incurred in connection with the restatement of certain of our previously issued financial statements.
08:32 EDTSPASparton Ultra Electronics USSI JV awarded $26.2M in contracts
Subscribe for More Information
September 16, 2014
08:34 EDTSPASparton enters into new $200M credit agreement
Subscribe for More Information
September 15, 2014
08:33 EDTSPASparton names Don Pearson as CFO, effective immediately
Subscribe for More Information
September 11, 2014
05:31 EDTPMCPharMerica initiated with a Neutral at Goldman
Subscribe for More Information
September 10, 2014
08:56 EDTPMCPharMerica announces commercial litigation vs. AmerisourceBergen
Subscribe for More Information
08:53 EDTPMCPharMerica raises FY14 adjusted EBITDA view to $123.2M-$126M
The company's previous adjusted EBITDA view was $121M-$123.5M. PharMerica’s decision to raise its FY14 guidance reflects positive momentum across the business, as well as the completed acquisition of three institutional pharmacies in Texas. Although financial terms of the transaction were not disclosed, PharMerica expects the acquisition to generate approximately $60M of annualized revenue and be immediately accretive to earnings in FY14. With this acquisition, PharMerica will have achieved its goal of completing acquisitions that generate at least $100M of annualized sales, in the aggregate, in FY14. PharMerica will again target acquisitions that generate at least $100M of annualized sales, in the aggregate, in 2015. The company noted that its FY14 guidance did not previously include the effect of FY14 acquisitions. PharMerica’s revised FY14 guidance now reflects the company’s acquisitions in FY14, which, in the aggregate, generate approximately $100M of annualized sales. The company said, "We remain focused on continuing this momentum, pursuing additional external growth opportunities, and delivering on our FY15 objectives. We believe that our strong foundation and focus on operational excellence, together with the significant potential upside from acquisitions, positions PharMerica to succeed and create meaningful long-term value for shareholders.”
08:47 EDTPMCPharMerica ups FY14 adjusted EPS view to $1.58-$1.62 from $1.47-$1.52
Subscribe for More Information
September 9, 2014
16:19 EDTSPASparton expects ro realize continued year over year EPS growth in FY15
Subscribe for More Information
16:17 EDTSPASparton reports Q4 adjusted EPS 56c, consensus 54c
Subscribe for More Information
07:12 EDTDIRIEuro Pacific to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use